They will explain how the medication works, potential side effects, and what to expect during treatment
While this research is still early, it may explain why some people develop diarrhea that persists beyond the typical 8 to 12 week adjustment window, and why probiotics have shown anecdotal benefit in managing GLP-1-related GI symptoms
Johansen NJ, Dejgaard TF, Lund A et al (2020) Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
In practical terms, that means it helps drive appetite suppression, improved satiety, slowed gastric emptying, and broader metabolic effects that go beyond what older single-pathway GLP-1 compounds were able to do